SEC Comment Letter 0000000000-24-003925 to IRADIMED CORP (IRMD)
IRADIMED CORP
Date: April 11, 2024 · CIK: 0001325618 · Accession: 0000000000-24-003925
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278487
Letter
United States securities and exchange commission logo April 11, 2024 Roger Susi President, Chief Executive Officer, Iradimed Corporation 1025 Willa Springs Drive Winter Springs, Florida 32708 Re:Iradimed Corporation Registration Statement on Form S-3 Filed April 3, 2024 File No. 333-278487 Dear Roger Susi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: David A. Bartz, Esq.
Show Raw Text
United States securities and exchange commission logo
April 11, 2024
Roger Susi
President, Chief Executive Officer,
Iradimed Corporation
1025 Willa Springs Drive
Winter Springs, Florida 32708
Re:Iradimed Corporation
Registration Statement on Form S-3
Filed April 3, 2024
File No. 333-278487
Dear Roger Susi:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: David A. Bartz, Esq.